Bound Volume Number
Volume III
Degree Type
Honors Capstone Project
Capstone Advisor
Thomas Fondy
Capstone Major
Biology
Capstone College
Arts and Science
Audio/Visual Component
no
Keywords
Low frequency ultrasound, mTOR, Rapamycin, Everolimus, Temsirolimus, Human Leukemia
Capstone Prize Winner
no
Won Capstone Funding
no
Honors Categories
Sciences and Engineering
Subject Categories
Biotechnology
Abstract
It has been shown that the mammalian target of rapamycin (mTOR) pathway, which regulates cell growth and proliferation, is aberrant in many hematological malignancies. Rapamycin inhibits mTOR signaling which regulates cell growth and cell cycle progression. This study sought to determine the effects of mTOR inhibitors on the cell sizes of normal and neoplastic cells and to determine ultrasonic sensitivity of normal and neoplastic cells treated with mTOR inhibitors. The effects of rapamycin (rapa), an extensively studied natural product that affects cell cycle entry by inhibiting mTORC1, and its analogs temsirolimus (tems) and everolimus (eve), were examined on leukemic cell lines (U937: Human monocytic leukemia, THP-1: Human acute monocytic lymphoma, K562: Human chronic myelogenous leukemia, and MOLT-4, Human acute lymphoblastic leukemia) in combination with 20kHz ultrasound. Each cell line was treated for 48 hours with each analog before being exposed to ultrasound. By using low frequency ultrasound of 5 pulses (0.6 seconds of ultrasound and 0.4 seconds without ultrasound) at 20 kHz and 30% amplitude (60W), we determined that as the concentrations of Rapa, Eve, and Tems (2, 20, and 50nM) increased, there is usually the most sonic damage observed in U937, MOLT-4, K562, and THP-1 cells. The most preferentially damaged cell line is K562 by all of the analogs and with all the concentrations used. In addition, larger cells were more susceptible to ultrasonic damage than were smaller cells. Further, there are no significant differences among the three analogs in the potentiation of ultrasonic damage. This preliminary therapeutic approach involving the use of ultra-sound in combination with mTOR inhibitors might eventually provide an improved approach to the treatment of leukemia and other hematological malignancies in a clinical setting.
Recommended Citation
Hemida, Yasmine, "Effect of Rapamycin as an Inhibitor of the mTOR Cell Cycle Entry Complex on the Selective Lysis of Human Leukemia Cells Lines in Vitro Using 20 kHz Pulsed Low-Frequency Ultrasound" (2016). Renée Crown University Honors Thesis Projects - All. 942.
https://surface.syr.edu/honors_capstone/942
Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.
